Top Authors

• Most frequent coverage on TKPHF.PK

• 
  Derek Lowe (135 followers)

  • Takeda Forced to Surrender DPP-IV Drug Market to Merck (Tue, Mar 17)
  • Can Takeda (or Roche, or Merck, or...) Afford to Ignore RNAi? (Thu, May 29)
  • Millennium Has Nothing to Fear from a Takeda Takeover (Sun, Apr 13)

  More by Derek Lowe on TKPHF.PK »
• 
  The Burrill Report (217 followers)

  • Pharma Spreads Holiday Cheer in Bevy of Biotech Deals (Thu, Dec 24)
  • Seattle Genetics Gets Boost from Cancer Drug Deal with Takeda (Sun, Dec 20)
  • This Week's Biotech Deal-Making and Financing (Sun, Dec 20)

  More by The Burrill Report on TKPHF.PK »
• 
  EP Vantage (72 followers)

  • Progenics: Investors Are Right To Be Wary (Wed, Oct 14)
  • New Diabetes Drug Could Give Januvia Stiff Competition (Tue, Aug 4)
  • Generic Players Continue to Impress in H1 (Thu, Jul 2)

  More by EP Vantage on TKPHF.PK »

• Most followed authors on TKPHF.PK

• 
  Zacks.com (1106 followers)

  • Amylin Takes Lead in Obesity Race (Tue, Nov 3)

  More by Zacks.com on TKPHF.PK »
• 
  SA Editor Eli Hoffmann (1060 followers)

  • FDA Wants Avandia to Carry Heart Attack Warning - WSJ (Wed, Oct 24)

  More by SA Editor Eli Hoffmann on TKPHF.PK »
• 
  Value Expectations (575 followers)

  • Ten Attractive Japanese Stocks (Thu, Oct 8)

  More by Value Expectations on TKPHF.PK »

• Newest authors on TKPHF.PK

• 
  TIP Guy (7 followers)

  • 31 Pan Asia Dividend Aristocrats (Mon, Aug 10)

  More by TIP Guy on TKPHF.PK »
• 
  The Burrill Report (217 followers)

  • Pharma Spreads Holiday Cheer in Bevy of Biotech Deals (Thu, Dec 24)
  • Seattle Genetics Gets Boost from Cancer Drug Deal with Takeda (Sun, Dec 20)
  • This Week's Biotech Deal-Making and Financing (Sun, Dec 20)

  More by The Burrill Report on TKPHF.PK »
• 
  Ruthanne Roussel (75 followers)

  • Don't Expect Amylin to Eat the Obesity Market's Lunch (Mon, Nov 2)

  More by Ruthanne Roussel on TKPHF.PK »

• Most commented on TKPHF.PK

• 
  Ruthanne Roussel (75 followers)

  • Don't Expect Amylin to Eat the Obesity Market's Lunch (Mon, Nov 2)

  More by Ruthanne Roussel on TKPHF.PK »
• 
  Derek Lowe (135 followers)

  • Takeda Forced to Surrender DPP-IV Drug Market to Merck (Tue, Mar 17)
  • Can Takeda (or Roche, or Merck, or...) Afford to Ignore RNAi? (Thu, May 29)
  • Millennium Has Nothing to Fear from a Takeda Takeover (Sun, Apr 13)

  More by Derek Lowe on TKPHF.PK »
• 
  The Society (258 followers)

  • Asian Dividends Catching My Eye (Wed, May 20)

  More by The Society on TKPHF.PK »